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Transfection of small non-coding RNAs (sncRNAs) molecules has become a 
routine technique widely used for silencing gene expression by triggering post-
transcriptional and transcriptional RNA interference (RNAi) pathways. Moreover, in the 
past decade, small activating (saRNA) sequences targeting promoter regions were also 
reported, thereby a RNA-based gene activation (RNAa) mechanism has been proposed. 
In this regard, Turner and colleagues recently discovered an endogenous microRNA 
(miRNA) which binds its promoter in order to upregulate its own expression. 
Interestingly, several miRNA-induced RNA activation (miRNAa) phenomena have 
since then been identified. My objective here is to introduce the reader into the 
emergent miRNAa research field, as well as bring together important discoveries about 
this unexplored transcriptional activation pathway.  
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Main text 
In the past decade, it was found that transfection of small double stranded RNA 
(dsRNA) molecules targeting promoter regions of the E-cadherin, vascular endothelial 
growth factor (VEGF) and p21 cyclin-dependent kinase inhibitor genes induced target 
transcriptional activation (Li et. 2006). Shortly after, Janowsky and colleagues (2007)
 
reported short RNA duplexes also able to induce target gene expression of the 
Progesterone Receptor (PR) gene. Such process was named RNA activation (RNAa), 
and transfected dsRNAs (19-21 nt) referred to as small activating RNAs (saRNAs) or 
antigen RNAs (agRNAs) (Li et al. 2006, Janowsky et al. 2007, Schwartz et al. 2008, 
Yang et al. 2008). The transfection of synthetic saRNAs into different cell lines has 
allowed to induce selective activation of target developmental genes involved in 
important cellular phenomena such as cell differentiation and apoptosis (Yang et al. 
2008, Zheng et al. 2014), and it has been reported in organisms as diverse as nematodes 
and mammals (Huang et al. 2010, 2013, Turner et al. 2014). Interestingly, several 
enzymes required for RNA interference (RNAi) including Dicer and Argonaute (Ago) 
family members have been also reported to function in RNAa (Li et al. 2006, Huang et 
 
 
 
 
 
 
 
4 
 
al. 2013, Place et al. 2008); however, saRNAs exhibit slower and more durable effects 
when compared to small interfering RNAs (siRNAs) (Li et al. 2006, Janowsky et al. 
2007). Functionally, saRNAs function to promote the assembly of the RNA Polymerase 
II (RNAPII) machinery on target promoters, and subsequently recruit heterogeneous 
nuclear ribonucleoproteins (hnRNPs), specific coactivators and chromatin remodeling 
factors which concertedly act to trigger gene activation (Schwartz  et al. 2008, Hu et al. 
2012, Huang et al. 2012). 
In higher eukaryotes, three main types of regulatory small non-coding RNAs 
(ncRNAs) have been identified: siRNAs, microRNAs (miRNAs) and piwi-interacting 
RNAs (piwi-RNAs). In particular, miRNAs are known to be evolutionarily conserved 
ncRNAs which target both DNA and RNA to inhibit gene expression. miRNA genes are 
first transcribed as long pri-miRNA stem-loop structures which are subsequently 
cleaved by Drosha and Dicer RNAses III enzymes to generate ∼70 nt long precursor 
miRNAs (pre-miRNAs), and mature miRNAs (21-22 nt), respectively (Lai 2002). In the 
cytoplasm, miRNAs inhibit translation by mRNA degradation/destabilization and 
translational repression, while in the nucleus these master regulators control transcript 
stability and recruit epigenetic remodeling factors in order to induce gene silencing 
(Catalanotto et al. 2016). Nonetheless, miRNAs can act not only to suppress, but also to 
induce expression of target genes. In 2008, Place et al. (2008) observed that transfection 
of synthetic miR-373 mimic targeting the region upstream of the transcription start site 
of the E-cadherin and the cold-shock domain-containing protein C2 (CSDC2) genes 
induced transcriptional activation in prostate cancer cell lines. Since then further 
miRNA-induced activation (miRNAa) phenomena have been reported (Table 1). In 
murine cell lines, miR-744 and miR-1186 target promoter of the Cyclin B1 (Ccnb1) 
gene to induce transcriptional activation (Huang et al. 2012). Interestingly, the authors 
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reported that knockdown of endogenous miR-744 significantly impaired mRNA 
expression of Ccnb1, thereby suggesting that miRNAa may represent a naturally 
occurring mechanism acting under physiological conditions. Likewise miRNAs 
involved in RNAi, activating miRNAs also require of (1) Drosha and Dicer RNase III 
enzymes, responsible for miRNA biogenesis, and (2) members of the Argonaute (Ago) 
family proteins, known to be associated with miRNAs during the formation of the 
effector RNA-Induced Silencing Complex (RISC) (Huang et al. 2012). 
It was not until 2014 that was reported the first experimental evidence of a 
miRNA acting endogenously to induce target gene expression. In nematodes, Turner 
and colleagues showed that miRNA lin-4 targets a putative lin-4-complementary 
element (LCE) situated at its promoter to trigger autoactivation. This evolutionary 
conserved miRNA (lin-4) was the first miRNA discovered, thereby its effects on gene 
expression are nowadays well known, especially its ability to regulate the activity of 
major developmental genes involved in post-embryonic growth (Lee et al. 1993). 
Importantly, Turner et al. (2014) observed that lin-4 mediates the recruitment of 
RNAPII to its own promoter and it is sufficient to trigger lin-4 miRNA autoactivation. 
Relevant research reports on miRNA activation phenomena were made using nematodes 
as experimental organism models. In C. elegans, it also was found that primary 
transcripts of let-7 miRNA interact with ALG-1 (Argonaute Like Gene 1), and this 
complex is responsible for processing of mature miRNAs from their corresponding 
precursors (Zisoulis et al. 2012). Moreover, activating miRNAs have also been reported 
to induce target host gene expression. In sarcoma cells, the Insulin-like growth factor 2 
(IGF2) gene is upregulated by a miRNA localized within one of its introns, miR-483-
5p, which targets the 5’ UTR of IGF2 mRNA transcripts (Liu et al. 2013). IGF2 is a 
tissue-specific maternally imprinted gene whose overexpression has been associated 
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with tumorigenesis (Ogawa 1993). Thus, miR-483-5p-mediated IGF2 gene expression 
would indicate that miRNAa plays an important role in the orchestration of complex 
epigenetic pathways such as involved in the control of gene imprinting. In support to 
this view, Liu et al. (2013) showed that miR-483-5p induces transcriptional activation 
through interaction of IGF2 with RHA (also known as DHX9), a RNA helicase which 
have been recently identified as a key component of the RNA-Induced Transcriptional 
Activation (RITA) complex (Portnoy et al. 2016). 
According to the experimental data, miRNAa does not fit a single model. Matsui 
et al. (2013) proposed that endogenous miR-589 induces target gene expression of the 
cyclooxygenase-2 (COX2) and phospholipase A2 (PLA2G4A) genes via a binding loop 
mechanism which includes gene promoters, nascent promoter COX2 transcript, 
Argonaute-2 (Ago2) and GW182, the last two being core components of the miRNA-
induced silencing complex (miRISC) (Carthew and Sontheimer 2009). It is important to 
note that the COX2 and PLA2G4A genes are located at a distance of only 149 kb, and 
they encode enzymes involved in the same inflammatory pathway. Likewise synthetic 
saRNAs, activating miRNAs may also produce site-specific epigenetic modifications 
(Li et al. 2006, Janowski et al. 2007, Huang et al. 2012, 2013, Matsui et al. 2013). In 
HEK293T cell lines, miR-24-1 overexpression is sufficient to trigger histone 3 lysine 27 
acetylation (H3K27ac) at target enhancers (Xiao et al. 2017). In contrast, however, 
miRNAa targeted to TATA-box motifs seem not to involve epigenetic marks at 
promoters sequences, as reported during activation of the interleukin-2 (IL-2) gene 
(Zhang et al. 2014b). In this regard, authors propose that miRNAs targeting TATA-box 
motifs might enhance the processivity of the RNAPII through the stabilization of the 
transcriptional machinery.  
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miRNAs are critical and versatile regulators that function in the nucleus to 
regulate gene expression, although how they do it is still an open question. In regard to 
the miRNAa mechanism, it has shown to require: 1- core components of the miRNA 
silencing pathway (i.e., Ago1, Ago2, Dicer and Drosha enzymes), 2- enrichment of 
RNAPII at target sites, and 3- epigenetic transcriptional reprogramming (Huang et al. 
2013, Place et al. 2008, Huang et al. 2012, Matsui et al. 2013, Dharap et al. 2013, 
Huang 2017). There are, however, important question about miRNAa, namely, how 
activating miRNAs act under physiological conditions, in which cellular 
processes/circumstances they are transcribed, etc. Importantly, advanced insight into 
RNA-based regulatory mechanisms would allow design effective and switchable 
strategies for controlling transcriptional networks. For instance, malfunctioning of the 
RNAi pathway by miRNA deregulation has been found to be associated with 
progression of tissue-specific tumors and faulty silencing of specific oncogenes, thereby 
activating miRNAs might be used to produce miRNAa-mediated transcriptional 
activation of target tumor suppressors. In conclusion, miRNAa is one of the hottest 
topics in current molecular biology and it is expected that a more deeply understanding 
about this emergent field render important insights into genome function, as well as 
promising therapeutic applications.  
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Table 1. miRNAs reported to target sequences and induce (or maintain) gene 
expression. The species from which cell lines/lineages have been derived are indicated 
in parentheses.  
miRNA 
Target gene 
sequence/genome region 
Cell lines used Reference 
miR-373 
E-cadherin (E-cad), cold-shock 
domain-containing C2 
(CSDC2) 
PC-3 (human) Place et al. (2008) 
miR-324-3p RelA   PC12 (rat) Dharap  et al. (2013) 
miR-483-5p 
Insulin-like growth factor 2 
(IGF2) 
MHH-ES-1, RD 
(human); F4328, 
F4864 (mouse) 
Liu et al. (2013) 
miR-589 Cyclooxygenase-2 (COX-2) A549 (human) Matsui  et al. (2013) 
miR-370-5p, 
miR-1180-5p 
and 
miR-1236-3p 
p21/CDKN1A 
T24, EJ, A549 
(human) 
Wang et al. (2014); Li et 
al. (2017a) 
miR-1236 p21/CDKN1A 
786-O, ACHN 
(human) 
Wang  et al. (2016) 
miR-3619-5p p21/CDKN1A DU145, PC3 (human) Li et al. (2017b) 
miR-6734 p21/CDKN1A HCT-116 (human) Kang  et al. (2016) 
let-7i Interleukin-2 (IL-2) 
CD4
+
 T-cells (human, 
mouse) 
Zhang et al. (2014b) 
miR-877-3p p16/CDKN2A T24, UM-UC-3 
(human) 
Li et al. (2016) 
miR-4281 FOXP3 CD4
+
 T-cells (human) Zhang et al. (2018) 
miR-551b-3p STAT3 
SKOV3, IGROV1, 
IOSE80 (human) 
Chaluvally-Raghavan et 
al. (2016) 
miR-24-1 Multiple enhancers HEK293T (human) Xiao et al. (2017) 
miR-140 long noncoding RNA NEAT1 3T3-L1 (mouse)  Gernapudi et al (2016) 
miR-744; miR-
1186 
Ccnb1/Cyclin B1 
NIH/3T3, TRAMP C1 
(mouse) 
Huang  et al. (2012) 
miR-H3 
Human immunodeficiency 
virus type 1 (HIV-1) 
HEK293T (human) Zhang  et al. (2014a) 
lin-4 lin-4 (autoregulation) 
Hypodermal seam 
cells (C. elegans) 
Turner et al. (2014) 
 
 
 
 
 
 
 
 
